Pronto disponible para inscripción

This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

BARDA: JUST BREATHE_BP-ARDS-P2-00 (Acute Respiratory Distress Syndrome) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this study to test different drugs to see if they are safe and helpful for adults who are admitted in the hospital with acute respiratory distress syndrome (ARDS) compared to placebo (a substance that looks like a drug but does not contain an active drug).

¿Cuál es la Condición que se está estudiando?

Acute Respiratory Distress Syndrome (ARDS)

¿Quién puede participar en el Estudio?

Adults ages 18+ who:

Are admitted to the hospital with a diagnosis of ARDS
Are not pregnant or nursing

For more information, contact the study team at kristy.johnson@duke.edu.

Grupo etario

Adultos

¿Qué Implica?

This study is called a platform study. A platform study is a study where several drugs are tested at the same time to figure out which drugs are most effective at helping resolve symptoms and restore people's health.

If you choose to join the study, you will get a random assignment to be treated with one of the following 4 options:

vilobelimab; OR
paridiprubart; OR
bevacizumab (Avastin®); OR
placebo

Detalles del Estudio

Título Completo

Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients with Acute Respiratory Distress Syndrome (ARDS) BP-ARDS-P2-001_(Advarra IRB)

Investigador Principal